AIMS & SCOPE

AIMS & SCOPE

Mega Journal of Oncology

Overview: Mega Journal of Oncology is an open-access, peer-reviewed international journal dedicated to publishing high-quality research and clinical advancements in oncology. It provides an inclusive platform for a wide range of topics such as cancer prevention, treatment, early detection, nutrition, and palliative care. The journal encourages contributions from oncologists, cancer specialists, primary care clinicians, and healthcare professionals, fostering an interdisciplinary approach to cancer care.


Key Features:

  • Open Access: All articles are freely accessible to everyone worldwide. This ensures maximum visibility for your work, allowing for wider dissemination and engagement with researchers, clinicians, and the general public.
  • Peer Review: The journal follows a rigorous peer-review process, ensuring that only high-quality, scientifically sound articles are published.
  • Creative Commons Attribution License: Your work can be shared and distributed freely under this license, provided proper attribution is given, ensuring a broader reach and impact.

Types of Articles Published:

Mega Journal of Oncology welcomes the submission of a variety of article types, including but not limited to:

  1. Research Articles: Original research on various aspects of oncology, including clinical trials, laboratory studies, and epidemiological findings.
  2. Review Articles: Comprehensive reviews of existing literature and emerging trends in the diagnosis, treatment, and prevention of cancer.
  3. Rare Clinical Cases: Detailed reports on uncommon cancer cases, contributing to the understanding and treatment of rare oncology conditions.
  4. Short Communications: Concise articles focused on a specific cancer-related topic, such as a new discovery, clinical observation, or breakthrough.
  5. Clinical Videos: Visual case studies or demonstrations that provide insights into advanced oncology procedures or novel treatments.
  6. Clinical Images: High-quality images depicting significant clinical observations, diagnostic results, or treatment procedures related to oncology.

Focus Areas:

Mega Journal of Oncology covers a broad spectrum of cancer-related topics, with an emphasis on:

  • Early Detection: Advancements in diagnostic technologies and methods for identifying cancer in its earliest stages.
  • Prevention: Research focused on preventing cancer through lifestyle, environmental, and genetic interventions.
  • Treatment: New therapeutic approaches, including chemotherapy, radiation, immunotherapy, and personalized medicine.
  • Nutrition: The role of diet and nutrition in cancer prevention, treatment, and patient recovery.
  • Palliative Care: Strategies and innovations in managing symptoms and improving the quality of life for cancer patients, particularly in the terminal stages.

Why Publish in Mega Journal of Oncology?

  1. High Visibility: With open-access publication, your research is available to anyone, ensuring that it reaches a global audience without barriers.
  2. Rapid Publication: Articles undergo a fast and efficient peer-review process, allowing for quicker dissemination of important findings.
  3. Impactful Reach: Articles are indexed in leading databases, improving the chances of your work being cited and widely recognized.
  4. Diverse Topics: The journal covers a wide array of cancer-related disciplines, providing a platform for all aspects of oncology research and practice.

Publication Ethics:

Mega Journal of Oncology follows the highest standards of publication ethics, ensuring transparency, fairness, and integrity in all aspects of the publishing process. The journal adheres to COPE (Committee on Publication Ethics) guidelines, and expects authors to follow strict ethical practices, including proper citation and disclosure of conflicts of interest.


Submission Guidelines:

  1. Manuscript Format:

    • Articles should be submitted in PDF or Word format.
    • Manuscripts should include sections like Abstract, Introduction, Materials and Methods, Results, Discussion, and References.
  2. Open Access Policy:

    • Articles are published with free access and available to the global community. Authors retain copyright under the Creative Commons Attribution License.
  3. Ethical Standards:

    • For studies involving human subjects, authors must comply with the Helsinki Declaration and provide informed consent from participants.
    • Ethics committee approval is required for studies involving animals.
    • Authors must disclose any conflicts of interest according to ICMJE guidelines.

Why Submit to Mega Journal of Oncology?

  • Global Exposure: Mega Journal of Oncology is committed to maximizing the reach of your work, ensuring that it is available to researchers and clinicians worldwide.
  • Expert Editorial Team: The journal is guided by a team of distinguished oncology professionals who ensure the highest standards of peer review.
  • Support for Interdisciplinary Research: The journal welcomes contributions from a wide range of oncology professionals, including medical oncologists, surgeons, radiologists, nutritionists, and palliative care specialists.

The Main Topics covered here:

Adolescent and Young Adult Oncology

Biochimica

Blastoma

Bone and Musculoskeletal Oncology

Breast Cancer

Cancer Immunology and Immunotherapy

Carcinoma

Gynecologic Oncology

Hormonal Therapy

Interventional Oncology

Medical Oncology

Molecular Oncology

Ocular Oncology

Pediatric Oncology

Psychological Oncology

Squamous Cell Carcinoma

Thoracic Oncology

Cardio Oncology

Chemotherapy

Clinical Oncology

Ophthalmic Surgery

Colorectal Carcinoma

Computational Oncology

Dermatological Oncology

Head and Neck Oncology

Immunotherapy

Leukemia

Melanoma

Neuro-Oncology

Oncology and Oral Health

Preventive Oncology

Radiation Oncology

Stages of Cancer

Tumorogenecity

Ductal Carcinoma

Epidemiological and Palliative care

Esophageal Cancer

Gastrointestinal Oncology

Genitourinary Oncology

Geriatric Oncology

Germ Cell Tumors

Hematological Oncology

Inhibition

Lymphoma

Molecular Cancer Therapeutics

Nuclear Medicine Oncology

Surgical Oncology

Prostate Cancer

Sarcoma

Targeted Therapy

Urological Oncology